|
시장보고서
상품코드
2050873
동종 줄기세포 이식 시장 : 공급원별, 용도별, 최종사용자별, 세포 유형별, 지역별Allogeneic Stem Cell Transplantation Market, By Source, By Application, By End User, By Cell Type, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
동종 조혈모세포 이식 시장은 2026년에 48억 9,000만 달러로 추정되며, 2033년까지 83억 8,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 8.0%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 48억 9,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 8.00% | 2033년 시장 규모 예측 : | 83억 8,000만 달러 |
동종 줄기세포 이식은 기증자의 줄기세포를 수혜자에게 이식하는 의료 시술입니다. 이러한 줄기세포는 골수, 말초혈액, 제대혈 등 다양한 공급원에서 채취할 수 있습니다. 이 시술의 목적은 손상되거나 질병에 걸린 세포를 건강한 세포로 대체하여 수혜자의 장기나 조직의 기능을 회복시키는 데 있습니다. 동종 줄기세포 이식은 암, 유전성 질환, 특정 면역계 질환 등 다양한 질환의 치료에 활용되고 있습니다.
세계 동종 줄기세포 이식 시장은 이 시술로 치료할 수 있는 질병의 유병률이 증가함에 따라 괄목할 만한 성장세를 보이고 있습니다. 또한, 이식 기술의 발전과 새로운 치료법의 개발도 시장 성장에 더욱 기여하고 있습니다. 이 시장에는 셀진코퍼레이션, 메소블라스트, 풀리스템 테라퓨틱스, 다케다약품공업 등 여러 주요 기업들이 진출해 있습니다.
시장 역학:
동종 줄기세포 이식 시장 시장 역학은 시장을 형성하는 시장 성장 촉진요인, 시장 성장 억제요인 및 기회를 통해 분석할 수 있습니다.
- 성장 촉진요인 : 백혈병, 림프종, 다발성 골수종 등 줄기세포 이식이 필요한 질환의 발생률 증가가 시장의 주요 촉진요인으로 작용하고 있습니다. 또한, 고령 인구 증가, 이식 기술의 발전, 줄기세포 은행 시설 증가도 시장 성장을 가속하고 있습니다.
- 성장 억제요인: 줄기세포 이식 수술에 따른 높은 비용과 이식편대숙주병(GVHD) 등의 합병증 위험이 시장의 큰 제약 요인으로 작용하고 있습니다. 또한, 특정 지역에서 동종 줄기세포 이식의 잠재적 이점에 대한 인식이 부족하다는 점도 시장 성장을 저해하는 요인입니다.
- 기회: 혁신적인 치료법 개발 및 동종 줄기세포 이식의 새로운 응용 분야 개척은 큰 성장 기회를 제공합니다. 또한, 연구개발 활동에 대한 투자 증가와 주요 기업 및 연구기관과의 협력도 시장 성장을 가속할 수 있습니다.
본 조사의 주요 특징:
- 이 보고서는 다양한 시장 세분화에서 잠재적인 수익 성장 기회를 강조하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 이 보고서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 세계 동종 줄기세포 이식 시장의 주요 기업으로는 셀진 코퍼레이션, 메소블라스트, 풀리스템 테라퓨틱스, 다케다약품공업(Takeda Pharmaceuticals, Inc.)을 조사했으며, 각 기업의 개요, 제품 포트폴리오, 주요 특징, 재무 실적, 전략 등을 바탕으로 프로파일을 작성했습니다. 작성되어 있습니다.
- 이 보고서는 마케팅 담당자와 경영진이 향후 제품 출시, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있는 귀중한 정보를 제공합니다.
- 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 의사결정을 위한 인사이트를 제공합니다.
- 이해관계자들은 세계 동종 줄기세포 이식 시장 분석에 사용된 다양한 전략 매트릭스를 활용하여 의사결정 과정을 원활하게 진행할 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 동종 줄기세포 이식 시장 : 소스별, 2021년-2033년
제5장 동종 줄기세포 이식 시장 : 세포 유형별, 2021년-2033년
제6장 동종 줄기세포 이식 시장 : 용도별, 2021년-2033년
제7장 동종 줄기세포 이식 시장 : 최종사용자별, 2021년-2033년
제8장 동종 줄기세포 이식 시장 : 지역별, 2021년-2033년
제9장 경쟁 구도
제10장 섹션
LSH 26.06.15Allogeneic Stem Cell Transplantation Market is estimated to be valued at USD 4.89 Bn in 2026 and is expected to reach USD 8.38 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4.89 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.00% | 2033 Value Projection: | USD 8.38 Bn |
Allogeneic stem cell transplantation is a medical procedure that involves the transfer of stem cells from a donor to a recipient. These stem cells can be obtained from various sources such as bone marrow, peripheral blood, or umbilical cord blood. The aim of this procedure is to replace damaged or diseased cells with healthy ones, thereby restoring the function of the recipient's organs or tissues. Allogeneic stem cell transplantation has been used for the treatment of a wide range of conditions including cancers, genetic disorders, and certain immune system disorders.
The global allogeneic stem cell transplantation market is witnessing significant growth due to the increasing prevalence of diseases that can be treated through this procedure. Moreover, advancements in transplantation techniques, as well as the development of new therapeutic approaches, are further contributing to the market growth. The market is characterized by the presence of several key players including Celgene Corporation, Mesoblast Ltd., Pluristem Therapeutics Inc., and Takeda Pharmaceutical Company Limited, among others.
Market Dynamics:
The market dynamics of the allogeneic stem cell transplantation market can be analyzed through the drivers, restraints, and opportunities that shape the market.
- Drivers: The increasing incidence of diseases that require stem cell transplantation, such as leukemia, lymphoma, and multiple myeloma, is a major driver for the market. Additionally, the growing geriatric population, advancements in transplantation techniques, and the rise in stem cell banking facilities are also fueling the market growth.
- Restraints: The high costs associated with stem cell transplantation procedures and the risk of complications, such as graft-versus-host disease, act as significant restraints for the market. Moreover, the lack of awareness about the potential benefits of allogeneic stem cell transplantation in certain regions hinders the market growth.
- Opportunities: The development of innovative therapies and the exploration of new applications for allogeneic stem cell transplantation present significant growth opportunities. Moreover, increasing investments in research and development activities and collaborations between key players and research institutions can drive the market growth.
Key Features of the Study:
- It highlights potential revenue growth opportunities across different market segments and explains attractive investment proposition matrices for this market
- The study offers key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- Key players in the global allogeneic stem cell transplantation market include Celgene Corporation, Mesoblast Ltd., Pluristem Therapeutics Inc., and Takeda Pharmaceutical Company Limited, and they are profiled based on company highlights, product portfolios, key highlights, financial performance, and strategies
- The report provides valuable information to marketers and management authorities, enabling them to make informed decisions regarding future product launches, market expansion, and marketing tactics
- It caters to various stakeholders in the industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts, providing them with insights for decision-making
- Stakeholders can benefit from the various strategy matrices used in analyzing the global allogeneic stem cell transplantation market, enhancing ease in decision-making processes
Allogeneic Stem Cell Transplantation Market Segmentation:
- By Source (Revenue, USD Bn, 2021 - 2033)
- Bone Marrow
- Peripheral Blood
- Umbilical Cord Blood
- Adipose Tissue
- Dental Pulp
- Others
- By Application (Revenue, USD Bn, 2021 - 2033)
- Cancer
- Autoimmune Diseases
- Blood Disorders
- Cardiac Disorders
- Neurological Disorders
- Diabetes
- Others
- By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Research Institutes
- Specialty Clinics
- Others
- By Cell Type (Revenue, USD Bn, 2021 - 2033)
- Allogeneic MSCs
- Allogeneic HSCs
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in the Allogeneic Stem Cell Transplantation Market:
- Celgene Corporation
- Mesoblast Ltd.
- Pluristem Therapeutics Inc.
- MEDIPOST Co., Ltd.
- Osiris Therapeutics, Inc.
- Cynata Therapeutics Limited
- Takeda Pharmaceutical Company Limited
- Astellas Pharma Inc.
- Cellular Biomedicine Group, Inc.
- Biosolution Co., Ltd.
- StemCell Technologies Inc.
- Caladrius Biosciences, Inc.
- TiGenix N.V.
- ViaCord
- Vericel Corporation
- Regen Biopharma Inc.
- Gamida Cell Ltd.
- Histogenics Corporation
- BrainStorm Cell Therapeutics Inc.
- Lineage Cell Therapeutics, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Allogeneic Stem Cell Transplantation Market , By Source
- Allogeneic Stem Cell Transplantation Market , By Cell Type
- Allogeneic Stem Cell Transplantation Market , By Application
- Allogeneic Stem Cell Transplantation Market , By End User
- Allogeneic Stem Cell Transplantation Market , By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Rising incidence of chronic diseases
- Restraints
- High costs associated with cell therapies
- Opportunities
- Increasing use of allogeneic MSCs
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Allogeneic Stem Cell Transplantation Market, By Source, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Bone Marrow
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Peripheral Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Umbilical Cord Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Adipose Tissue
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Dental Pulp
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
5. Allogeneic Stem Cell Transplantation Market, By Cell Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Allogeneic MSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Allogeneic HSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
6. Allogeneic Stem Cell Transplantation Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Blood Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Cardiac Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
7. Allogeneic Stem Cell Transplantation Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
8. Allogeneic Stem Cell Transplantation Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2023and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Celgene Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mesoblast Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pluristem Therapeutics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- MEDIPOST Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Osiris Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cynata Therapeutics Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cellular Biomedicine Group, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Biosolution Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- StemCell Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Caladrius Biosciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- ViaCord
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Vericel Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Regen Biopharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Gamida Cell Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Histogenics Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BrainStorm Cell Therapeutics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lineage Cell Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
